BAKER BROS. ADVISORS LP
Director; Director, 10% Owner; Other · 23 filings · Latest: Sep 30, 2026
ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Celcuity Inc.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Kodiak Sciences Inc.
Kymera Therapeutics, Inc.
MADRIGAL PHARMACEUTICALS, INC.
Prelude Therapeutics Inc
Replimune Group, Inc.
TScan Therapeutics, Inc.
vTv Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KOD | BAKER BROS. ADVISORS LP | Director, 10% Owner | Sep 29, 2026 | Purchase | $85.05 | 33,726 | $2.9M | 20,191,214 | |
KOD | BAKER BROS. ADVISORS LP | Director, 10% Owner | Sep 28, 2026 | Purchase | $88.77 | 681,866 | $60.5M | 20,159,386 | |
KOD | BAKER BROS. ADVISORS LP | Director, 10% Owner | Sep 28, 2026 | Purchase | $83.58 | 418,323 | $35.0M | 19,515,907 | |
KOD | BAKER BROS. ADVISORS LP | Director, 10% Owner | Sep 28, 2026 | Purchase | $72.57 | 807,840 | $58.6M | 19,121,134 | |
CELC | BAKER BROS. ADVISORS LP | Other | Jul 14, 2026 | Sale | $102.50 | 3,100,000 | $317.8M | 4,372,852 | |
ONC | BAKER BROS. ADVISORS LP | Director | May 22, 2026 | Sale | $23.82 | 10,998 | $262.0K | 142,570 | |
INCY | BAKER BROS. ADVISORS LP | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 |